| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of 1 Ophthalmology and 7 Pediatrics, The University of Iowa College of Medicine, Iowa City; 2 Hôpital Jules Gonin, Lausanne, Switzerland; 3 Division de Génétique Médicale, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland; 4 University of Illinois Eye and Ear Infirmary, Chicago; 5 The Casey Eye Institute, Portland, Oregon; the 6 Department of Ophthalmology, Scheie Eye Institute, Philadelphia, Pennsylvania; and the 8 Howard Hughes Medical Institute, Iowa City.
PURPOSE. To assess the allelic variation of the VMD2 gene in patients with Best disease and age-related macular degeneration (AMD).
METHODS. Three hundred twenty-one AMD patients, 192 ethnically similar control subjects, 39 unrelated probands with familial Best disease, and 57 unrelated probands with the ophthalmoscopic findings of Best disease but no family history were screened for sequence variations in the VMD2 gene by single-strand conformation polymorphism (SSCP) analysis. Amplimers showing a bandshift were reamplified and sequenced bidirectionally. In addition, the coding regions of the VMD2 gene were completely sequenced in six probands with familial Best disease who showed no SSCP shift.
RESULTS. Forty different probable or possible disease-causing mutations were found in one or more Best disease or AMD patients. Twenty-nine of these variations are novel. Of the 39 probands with familial Best disease, mutations were detected in all 39 (33 by SSCP and 6 by DNA sequencing). SSCP screening of the 57 probands with a clinical diagnosis of Best disease but no family history revealed 16 with mutations. Mutations were found in 5 of 321 AMD patients (1.5%), a fraction that was not significantly greater than in control individuals (0/192, 0%).
CONCLUSIONS. Patients with the clinical diagnosis of Best disease are significantly more likely to have a mutation in the VMD2 gene if they also have a positive family history. These findings suggest that a small fraction of patients with the clinical diagnosis of AMD may actually have a late-onset variant of Best disease, whereas at the same time, a considerable fraction of isolated patients with the ophthalmoscopic features of Best disease are probably affected with some other macular disease.
This article has been cited by other articles:
|
|
 |
|
  H. C. Hartzell, Z. Qu, K. Yu, Q. Xiao, and L.-T. Chien Molecular Physiology of Bestrophins: Multifunctional Membrane Proteins Linked to Best Disease and Other Retinopathies Physiol Rev, April 1, 2008; 88(2): 639 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Swaroop, K. E. Branham, W. Chen, and G. Abecasis Genetic susceptibility to age-related macular degeneration: a paradigm for dissecting complex disease traits Hum. Mol. Genet., October 15, 2007; 16(R2): R174 - R182. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Yu, Z. Qu, Y. Cui, and H. C. Hartzell Chloride Channel Activity of Bestrophin Mutants Associated with Mild or Late-Onset Macular Degeneration Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4694 - 4705. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. F. Boon, B. J. Klevering, A. I. den Hollander, M. N. Zonneveld, T. Theelen, F. P. M. Cremers, and C. B. Hoyng Clinical and Genetic Heterogeneity in Multifocal Vitelliform Dystrophy Arch Ophthalmol, August 1, 2007; 125(8): 1100 - 1106. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Mullins, M. H. Kuehn, E. A. Faidley, N. A. Syed, and E. M. Stone Differential Macular and Peripheral Expression of Bestrophin in Human Eyes and Its Implication for Best Disease Invest. Ophthalmol. Vis. Sci., July 1, 2007; 48(7): 3372 - 3380. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Guziewicz, B. Zangerl, S. J. Lindauer, R. F. Mullins, L. S. Sandmeyer, B. H. Grahn, E. M. Stone, G. M. Acland, and G. D. Aguirre Bestrophin Gene Mutations Cause Canine Multifocal Retinopathy: A Novel Animal Model for Best Disease Invest. Ophthalmol. Vis. Sci., May 1, 2007; 48(5): 1959 - 1967. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D Marchant, K Yu, K Bigot, O Roche, A Germain, D Bonneau, V Drouin-Garraud, D F Schorderet, F Munier, D Schmidt, et al. New VMD2 gene mutations identified in patients affected by Best vitelliform macular dystrophy J. Med. Genet., March 1, 2007; 44(3): e70 - e70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Gorin A Clinician's View of the Molecular Genetics of Age-Related Maculopathy Arch Ophthalmol, January 1, 2007; 125(1): 21 - 29. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yu, Y. Cui, and H. C. Hartzell The Bestrophin Mutation A243V, Linked to Adult-Onset Vitelliform Macular Dystrophy, Impairs Its Chloride Channel Function Invest. Ophthalmol. Vis. Sci., November 1, 2006; 47(11): 4956 - 4961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Apushkin, G. A. Fishman, C. M. Taylor, and E. M. Stone Novel de novo mutation in a patient with Best macular dystrophy. Arch Ophthalmol, June 1, 2006; 124(6): 887 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. F. Mullins, K. T. Oh, E. Heffron, G. S. Hageman, and E. M. Stone Late Development of Vitelliform Lesions and Flecks in a Patient With Best Disease: Clinicopathologic Correlation Arch Ophthalmol, November 1, 2005; 123(11): 1588 - 1594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Strauss The Retinal Pigment Epithelium in Visual Function Physiol Rev, July 1, 2005; 85(3): 845 - 881. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Loewen and G. W. Forsyth Structure and Function of CLCA Proteins Physiol Rev, July 1, 2005; 85(3): 1061 - 1092. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Campos, V. Forjaz, L. R. Kozak, E. Silva, and M. Castelo-Branco Quantitative Phenotyping of Chromatic Dysfunction in Best Macular Dystrophy Arch Ophthalmol, July 1, 2005; 123(7): 944 - 949. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. M. Stone, T. A. Braun, S. R. Russell, M. H. Kuehn, A. J. Lotery, P. A. Moore, C. G. Eastman, T. L. Casavant, and V. C. Sheffield Missense Variations in the Fibulin 5 Gene and Age-Related Macular Degeneration N. Engl. J. Med., July 22, 2004; 351(4): 346 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tsunenari, H. Sun, J. Williams, H. Cahill, P. Smallwood, K.-W. Yau, and J. Nathans Structure-Function Analysis of the Bestrophin Family of Anion Channels J. Biol. Chem., October 17, 2003; 278(42): 41114 - 41125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M Michaelides, D M Hunt, and A T Moore The genetics of inherited macular dystrophies J. Med. Genet., September 1, 2003; 40(9): 641 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Bakall, L. Y. Marmorstein, G. Hoppe, N. S. Peachey, C. Wadelius, and A. D. Marmorstein Expression and Localization of Bestrophin during Normal Mouse Development Invest. Ophthalmol. Vis. Sci., August 1, 2003; 44(8): 3622 - 3628. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schmidt, E. A. Postel, A. Agarwal, I. C. Allen Jr, S. N. Walters, M. A. De La Paz, W. K. Scott, J. L. Haines, M. A. Pericak-Vance, and J. R. Gilbert Detailed Analysis of Allelic Variation in the ABCA4 Gene in Age-Related Maculopathy Invest. Ophthalmol. Vis. Sci., July 1, 2003; 44(7): 2868 - 2875. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Y. Marmorstein, P. J. McLaughlin, J. B. Stanton, L. Yan, J. W. Crabb, and A. D. Marmorstein Bestrophin Interacts Physically and Functionally with Protein Phosphatase 2A J. Biol. Chem., August 16, 2002; 277(34): 30591 - 30597. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Sun, T. Tsunenari, K.-W. Yau, and J. Nathans The vitelliform macular dystrophy protein defines a new family of chloride channels PNAS, March 19, 2002; 99(6): 4008 - 4013. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. M. Stone, V. C. Sheffield, and G. S. Hageman Molecular genetics of age-related macular degeneration Hum. Mol. Genet., October 1, 2001; 10(20): 2285 - 2292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G Sauer, K. White, H. Stohr, T. Grimm, A. Hutchinson, P. S Bernstein, R. A. Lewis, F. Simonelli, D. Pauleikhoff, R. Allikmets, et al. Evaluation of the G protein coupled receptor-75 (GPR75) in age related macular degeneration Br. J. Ophthalmol., August 1, 2001; 85(8): 969 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Webster, E. Héon, A. J. Lotery, K. Vandenburgh, T. L. Casavant, K. T. Oh, G. Beck, G. A. Fishman, B. L. Lam, A. Levin, et al. An Analysis of Allelic Variation in the ABCA4 Gene Invest. Ophthalmol. Vis. Sci., May 1, 2001; 42(6): 1179 - 1189. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. Marmorstein, L. Y. Marmorstein, M. Rayborn, X. Wang, J. G. Hollyfield, and K. Petrukhin Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium PNAS, October 23, 2000; (2000) 220402097. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. Marmorstein, L. Y. Marmorstein, M. Rayborn, X. Wang, J. G. Hollyfield, and K. Petrukhin Bestrophin, the product of the Best vitelliform macular dystrophy gene (VMD2), localizes to the basolateral plasma membrane of the retinal pigment epithelium PNAS, November 7, 2000; 97(23): 12758 - 12763. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
